Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort

Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort

Sebastian Bernuth,1 Daniel Grimm,1 Johanna Vollmar,1 Felix Darstein,1 Jens Mittler,2 Michael Heise,2 Maria Hoppe-Lotichius,2 Peter R Galle,1 Hauke Lang,2 Tim Zimmermann1 1First Department of Internal Medicine, Transplant Hepatology, 2General-, Abdominal- and Transplant- Surgery, University Medical...

Full description

Bibliographic Details
Main Authors: Bernuth S, Grimm D, Vollmar J, Darstein F, Mittler J, Heise M, Hoppe-Lotichius M, Galle PR, Lang H, Zimmermann T
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Drug Design, Development and Therapy
Subjects:
HCV
hepatitis C
DAA
direct acting antivirals
liver transplantation
sofosbuvir
Online Access:https://www.dovepress.com/efficacy-and-safety-of-direct-acting-antiviral-therapy-in-previous-har-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/efficacy-and-safety-of-direct-acting-antiviral-therapy-in-previous-har-peer-reviewed-article-DDDT

Similar Items